The week in health tech, explained in plain English.Get the free newsletter →
November 8, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Government

GOP Pushes Fraud Message to Deflect Healthcare Cost Anger

Republicans are putting anti-fraud enforcement at the center of their healthcare pitch heading into the midterms, casting crackdowns on Medicaid and Affordable Care Act spending as a defense of taxpayer money, KFF Health News reports. The strategy arrives as voters express mounting frustration over healthcare affordability, giving the GOP a way to redirect that anger toward "bad actors" rather than premiums and out-of-pocket costs.

Democrats counter that the administration is using fraud claims, with insufficient evidence, to single out blue states and lay groundwork for shrinking programs the party has long wanted to cut. The dispute reflects a deeper fight over the future of Medicaid and the ACA, two programs that cover tens of millions of Americans.

For health systems, insurers, and state agencies, the practical stakes are real. Intensified fraud investigations can translate into audits, funding uncertainty, and tighter eligibility rules, all of which ripple into coverage, reimbursement, and administrative burden well before any votes are cast.

More in Government

Government

BIO Sues to Block Medicare Peer-Country Drug Pricing Pilot

BIO has sued to block a Medicare pilot that ties certain US drug prices to peer-country benchmarks, the latest challenge to Trump's most-favored-nation pricing push.

Why it matters: The outcome will shape how far the federal government can use Medicare pilots to push US drug prices toward what other countries pay.

Government

CMS Finalizes 2.4% Home Health Pay Bump for 2027

CMS finalized a 2.4% home health payment increase for 2027 while tightening Medicare provider enrollment rules to fight fraud.

Why it matters: The rule sets 2027 reimbursement for home health agencies and raises compliance stakes as CMS cracks down on fraud.

Government

CMS Makes Medicare Drug Price Negotiation Rules Permanent

CMS finalized a rule making its Medicare Drug Price Negotiation Program framework permanent, setting lasting policies for negotiated prices starting in 2029.

Why it matters: A permanent framework gives drugmakers, payers, and providers a stable rulebook to plan pricing and contracting around instead of chasing year-by-year changes.